Global Structural Heart Devices

Structural Heart Devices Comprehensive Study by Type (Herat Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems, Annuloplasty Rings, Other Devices, Accessories), Indication (Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Patent Foramen Ovale (PFO), Aortic Valve Stenosis, Others), Procedure (Replacement Procedures, TAVR Procedures, SAVR Procedures, Repair Procedures, Closure Procedures, Annuloplasty, Valvuloplasty, TMVR Procedures), Age Group (Pediatric, Adults), End User (Hospitals, Ambulatory Surgical Centers) Players and Region - Global Market Outlook to 2026

Structural Heart Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Structural Heart Devices Market Scope
The structural heart devices market is expected to grow in the future due to a rise in mitral regurgitation, aortic stenosis, and other related heart diseases. Structural heart disease refers to patients suffering from both congenital heart disease and acquired heart disease involving structural and functional abnormalities of heart valves, proximal great vessels, and cardiac chambers. Increasing R&D activities by key players on structural heart devices and an upsurge in demand for quick and long-lasting procedures among the geriatric population are fueling the growth of the structural heart devices market in the forecasted period.

The Structural Heart Devices market study is segmented by Type (Herat Valve Devices, Surgical Heart Valves, Transcatheter Heart Valves, Occluders and Delivery Systems, Annuloplasty Rings, Other Devices and Accessories) and major geographies with country level break-up.

The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Structural Heart Devices market throughout the predicted period.

Edwards Lifesciences Corporation (United States), Medtronic plc (Ireland), Abbott (United States), Boston Scientific Corporation (United States), LivaNova plc (United Kingdom), CryoLife, Inc. (United States), Micro Interventional Devices, Inc. (United States), Braile Biomédica (Brazil), Lepu Medical Technology (Beijing) Co., Ltd. (China) and TTK Healthcare Limited (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Biomerics (United States) and Lifetech Scientific (China).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Structural Heart Devices market by Type, Application and Region.

On the basis of geography, the market of Structural Heart Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
In may 2020, Sahajanand Medical Technologies (SMT) announced its entry into the structural heart segment with an acquisition of medical device firm Vascular Concepts. The acquisition got completed on May 27. Even after the acquisition, Vascular Concept will retain its distinct brand and independence. Swaminathan Jayaraman, CEO, Vascular Concepts will continue to manage the operation of the company.
In Dec 2020, LivaNova PLC and Gyrus Capital (Gyrus) announced they have entered into an agreement whereby entities funded and controlled by Gyrus will acquire the LivaNova heart valve (HV) business. Gyrus intends to focus management attention and investment on the HV business to position it to become a leading player in the surgical heart valve market globally, translating into even greater opportunities for employees, customers, and patients.


Market Trend
  • Technological Advancements in Structural Heart Devices
  • Increasing R&D Activities by Key Players on Structural Heart Devices

Market Drivers
  • Rising Incidence of Structural Heart Diseases
  • Increasing Demand for Minimally Invasive Techniques

Opportunities
  • Surging Development of Innovative Repair Sevices such as Annuloplasty Rings, Occluders, Etc
  • Growth in the Healthcare Industry Worldwide

Restraints
  • High Cost of Surgeries
  • Inaccessibility of Cardiac Surgeries in Emerging Economies

Challenges
  • Stringent Government Regulations
  • Lack of Skilled Personnel


Key Target Audience
New Entrants/Investors, Healthcare Industry Associations, Venture Capitalists and Private Equity Firms, Valvular Heart Diseases Treatment Provider, Raw Material Suppliers, End-Use Industries and Analysts and Strategic Business Planners

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase

Report Objectives / Segmentation Covered

By Type
  • Herat Valve Devices
  • Surgical Heart Valves
  • Transcatheter Heart Valves
  • Occluders and Delivery Systems
  • Annuloplasty Rings
  • Other Devices
  • Accessories
By Indication
  • Atrial Septal Defect (ASD)
  • Ventricular Septal Defect (VSD)
  • Patent Foramen Ovale (PFO)
  • Aortic Valve Stenosis
  • Others

By Procedure
  • Replacement Procedures
  • TAVR Procedures
  • SAVR Procedures
  • Repair Procedures
  • Closure Procedures
  • Annuloplasty
  • Valvuloplasty
  • TMVR Procedures

By Age Group
  • Pediatric
  • Adults

By End User
  • Hospitals
  • Ambulatory Surgical Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Incidence of Structural Heart Diseases
      • 3.2.2. Increasing Demand for Minimally Invasive Techniques
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations
      • 3.3.2. Lack of Skilled Personnel
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Structural Heart Devices
      • 3.4.2. Increasing R&D Activities by Key Players on Structural Heart Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Structural Heart Devices, by Type, Indication, Procedure, Age Group, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Structural Heart Devices (Value)
      • 5.2.1. Global Structural Heart Devices by: Type (Value)
        • 5.2.1.1. Herat Valve Devices
        • 5.2.1.2. Surgical Heart Valves
        • 5.2.1.3. Transcatheter Heart Valves
        • 5.2.1.4. Occluders and Delivery Systems
        • 5.2.1.5. Annuloplasty Rings
        • 5.2.1.6. Other Devices
        • 5.2.1.7. Accessories
      • 5.2.2. Global Structural Heart Devices by: Indication (Value)
        • 5.2.2.1. Atrial Septal Defect (ASD)
        • 5.2.2.2. Ventricular Septal Defect (VSD)
        • 5.2.2.3. Patent Foramen Ovale (PFO)
        • 5.2.2.4. Aortic Valve Stenosis
        • 5.2.2.5. Others
      • 5.2.3. Global Structural Heart Devices by: Procedure (Value)
        • 5.2.3.1. Replacement Procedures
        • 5.2.3.2. TAVR Procedures
        • 5.2.3.3. SAVR Procedures
        • 5.2.3.4. Repair Procedures
        • 5.2.3.5. Closure Procedures
        • 5.2.3.6. Annuloplasty
        • 5.2.3.7. Valvuloplasty
        • 5.2.3.8. TMVR Procedures
      • 5.2.4. Global Structural Heart Devices by: Age Group (Value)
        • 5.2.4.1. Pediatric
        • 5.2.4.2. Adults
      • 5.2.5. Global Structural Heart Devices by: End User (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Ambulatory Surgical Centers
      • 5.2.6. Global Structural Heart Devices Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Structural Heart Devices (Volume)
      • 5.3.1. Global Structural Heart Devices by: Type (Volume)
        • 5.3.1.1. Herat Valve Devices
        • 5.3.1.2. Surgical Heart Valves
        • 5.3.1.3. Transcatheter Heart Valves
        • 5.3.1.4. Occluders and Delivery Systems
        • 5.3.1.5. Annuloplasty Rings
        • 5.3.1.6. Other Devices
        • 5.3.1.7. Accessories
      • 5.3.2. Global Structural Heart Devices by: Indication (Volume)
        • 5.3.2.1. Atrial Septal Defect (ASD)
        • 5.3.2.2. Ventricular Septal Defect (VSD)
        • 5.3.2.3. Patent Foramen Ovale (PFO)
        • 5.3.2.4. Aortic Valve Stenosis
        • 5.3.2.5. Others
      • 5.3.3. Global Structural Heart Devices by: Procedure (Volume)
        • 5.3.3.1. Replacement Procedures
        • 5.3.3.2. TAVR Procedures
        • 5.3.3.3. SAVR Procedures
        • 5.3.3.4. Repair Procedures
        • 5.3.3.5. Closure Procedures
        • 5.3.3.6. Annuloplasty
        • 5.3.3.7. Valvuloplasty
        • 5.3.3.8. TMVR Procedures
      • 5.3.4. Global Structural Heart Devices by: Age Group (Volume)
        • 5.3.4.1. Pediatric
        • 5.3.4.2. Adults
      • 5.3.5. Global Structural Heart Devices by: End User (Volume)
        • 5.3.5.1. Hospitals
        • 5.3.5.2. Ambulatory Surgical Centers
      • 5.3.6. Global Structural Heart Devices Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Structural Heart Devices (Price)
      • 5.4.1. Global Structural Heart Devices by: Type (Price)
  • 6. Structural Heart Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Edwards Lifesciences Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. LivaNova plc (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. CryoLife, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Micro Interventional Devices, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Braile Biomédica (Brazil)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Lepu Medical Technology (Beijing) Co., Ltd. (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. TTK Healthcare Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Structural Heart Devices Sale, by Type, Indication, Procedure, Age Group, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Structural Heart Devices (Value)
      • 7.2.1. Global Structural Heart Devices by: Type (Value)
        • 7.2.1.1. Herat Valve Devices
        • 7.2.1.2. Surgical Heart Valves
        • 7.2.1.3. Transcatheter Heart Valves
        • 7.2.1.4. Occluders and Delivery Systems
        • 7.2.1.5. Annuloplasty Rings
        • 7.2.1.6. Other Devices
        • 7.2.1.7. Accessories
      • 7.2.2. Global Structural Heart Devices by: Indication (Value)
        • 7.2.2.1. Atrial Septal Defect (ASD)
        • 7.2.2.2. Ventricular Septal Defect (VSD)
        • 7.2.2.3. Patent Foramen Ovale (PFO)
        • 7.2.2.4. Aortic Valve Stenosis
        • 7.2.2.5. Others
      • 7.2.3. Global Structural Heart Devices by: Procedure (Value)
        • 7.2.3.1. Replacement Procedures
        • 7.2.3.2. TAVR Procedures
        • 7.2.3.3. SAVR Procedures
        • 7.2.3.4. Repair Procedures
        • 7.2.3.5. Closure Procedures
        • 7.2.3.6. Annuloplasty
        • 7.2.3.7. Valvuloplasty
        • 7.2.3.8. TMVR Procedures
      • 7.2.4. Global Structural Heart Devices by: Age Group (Value)
        • 7.2.4.1. Pediatric
        • 7.2.4.2. Adults
      • 7.2.5. Global Structural Heart Devices by: End User (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Ambulatory Surgical Centers
      • 7.2.6. Global Structural Heart Devices Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Structural Heart Devices (Volume)
      • 7.3.1. Global Structural Heart Devices by: Type (Volume)
        • 7.3.1.1. Herat Valve Devices
        • 7.3.1.2. Surgical Heart Valves
        • 7.3.1.3. Transcatheter Heart Valves
        • 7.3.1.4. Occluders and Delivery Systems
        • 7.3.1.5. Annuloplasty Rings
        • 7.3.1.6. Other Devices
        • 7.3.1.7. Accessories
      • 7.3.2. Global Structural Heart Devices by: Indication (Volume)
        • 7.3.2.1. Atrial Septal Defect (ASD)
        • 7.3.2.2. Ventricular Septal Defect (VSD)
        • 7.3.2.3. Patent Foramen Ovale (PFO)
        • 7.3.2.4. Aortic Valve Stenosis
        • 7.3.2.5. Others
      • 7.3.3. Global Structural Heart Devices by: Procedure (Volume)
        • 7.3.3.1. Replacement Procedures
        • 7.3.3.2. TAVR Procedures
        • 7.3.3.3. SAVR Procedures
        • 7.3.3.4. Repair Procedures
        • 7.3.3.5. Closure Procedures
        • 7.3.3.6. Annuloplasty
        • 7.3.3.7. Valvuloplasty
        • 7.3.3.8. TMVR Procedures
      • 7.3.4. Global Structural Heart Devices by: Age Group (Volume)
        • 7.3.4.1. Pediatric
        • 7.3.4.2. Adults
      • 7.3.5. Global Structural Heart Devices by: End User (Volume)
        • 7.3.5.1. Hospitals
        • 7.3.5.2. Ambulatory Surgical Centers
      • 7.3.6. Global Structural Heart Devices Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Structural Heart Devices (Price)
      • 7.4.1. Global Structural Heart Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Structural Heart Devices: by Type(USD Million)
  • Table 2. Structural Heart Devices Herat Valve Devices , by Region USD Million (2015-2020)
  • Table 3. Structural Heart Devices Surgical Heart Valves , by Region USD Million (2015-2020)
  • Table 4. Structural Heart Devices Transcatheter Heart Valves , by Region USD Million (2015-2020)
  • Table 5. Structural Heart Devices Occluders and Delivery Systems , by Region USD Million (2015-2020)
  • Table 6. Structural Heart Devices Annuloplasty Rings , by Region USD Million (2015-2020)
  • Table 7. Structural Heart Devices Other Devices , by Region USD Million (2015-2020)
  • Table 8. Structural Heart Devices Accessories , by Region USD Million (2015-2020)
  • Table 9. Structural Heart Devices: by Indication(USD Million)
  • Table 10. Structural Heart Devices Atrial Septal Defect (ASD) , by Region USD Million (2015-2020)
  • Table 11. Structural Heart Devices Ventricular Septal Defect (VSD) , by Region USD Million (2015-2020)
  • Table 12. Structural Heart Devices Patent Foramen Ovale (PFO) , by Region USD Million (2015-2020)
  • Table 13. Structural Heart Devices Aortic Valve Stenosis , by Region USD Million (2015-2020)
  • Table 14. Structural Heart Devices Others , by Region USD Million (2015-2020)
  • Table 15. Structural Heart Devices: by Procedure(USD Million)
  • Table 16. Structural Heart Devices Replacement Procedures , by Region USD Million (2015-2020)
  • Table 17. Structural Heart Devices TAVR Procedures , by Region USD Million (2015-2020)
  • Table 18. Structural Heart Devices SAVR Procedures , by Region USD Million (2015-2020)
  • Table 19. Structural Heart Devices Repair Procedures , by Region USD Million (2015-2020)
  • Table 20. Structural Heart Devices Closure Procedures , by Region USD Million (2015-2020)
  • Table 21. Structural Heart Devices Annuloplasty , by Region USD Million (2015-2020)
  • Table 22. Structural Heart Devices Valvuloplasty , by Region USD Million (2015-2020)
  • Table 23. Structural Heart Devices TMVR Procedures , by Region USD Million (2015-2020)
  • Table 24. Structural Heart Devices: by Age Group(USD Million)
  • Table 25. Structural Heart Devices Pediatric , by Region USD Million (2015-2020)
  • Table 26. Structural Heart Devices Adults , by Region USD Million (2015-2020)
  • Table 27. Structural Heart Devices: by End User(USD Million)
  • Table 28. Structural Heart Devices Hospitals , by Region USD Million (2015-2020)
  • Table 29. Structural Heart Devices Ambulatory Surgical Centers , by Region USD Million (2015-2020)
  • Table 30. South America Structural Heart Devices, by Country USD Million (2015-2020)
  • Table 31. South America Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 32. South America Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 33. South America Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 34. South America Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 35. South America Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 36. Brazil Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 37. Brazil Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 38. Brazil Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 39. Brazil Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 40. Brazil Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 41. Argentina Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 42. Argentina Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 43. Argentina Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 44. Argentina Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 45. Argentina Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 46. Rest of South America Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 47. Rest of South America Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 48. Rest of South America Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 49. Rest of South America Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 50. Rest of South America Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 51. Asia Pacific Structural Heart Devices, by Country USD Million (2015-2020)
  • Table 52. Asia Pacific Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 53. Asia Pacific Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 54. Asia Pacific Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 55. Asia Pacific Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 56. Asia Pacific Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 57. China Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 58. China Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 59. China Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 60. China Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 61. China Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 62. Japan Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 63. Japan Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 64. Japan Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 65. Japan Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 66. Japan Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 67. India Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 68. India Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 69. India Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 70. India Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 71. India Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 72. South Korea Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 73. South Korea Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 74. South Korea Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 75. South Korea Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 76. South Korea Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 77. Taiwan Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 78. Taiwan Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 79. Taiwan Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 80. Taiwan Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 81. Taiwan Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 82. Australia Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 83. Australia Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 84. Australia Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 85. Australia Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 86. Australia Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 87. Rest of Asia-Pacific Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 88. Rest of Asia-Pacific Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 89. Rest of Asia-Pacific Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 90. Rest of Asia-Pacific Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 91. Rest of Asia-Pacific Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 92. Europe Structural Heart Devices, by Country USD Million (2015-2020)
  • Table 93. Europe Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 94. Europe Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 95. Europe Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 96. Europe Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 97. Europe Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 98. Germany Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 99. Germany Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 100. Germany Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 101. Germany Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 102. Germany Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 103. France Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 104. France Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 105. France Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 106. France Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 107. France Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 108. Italy Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 109. Italy Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 110. Italy Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 111. Italy Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 112. Italy Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 113. United Kingdom Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 114. United Kingdom Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 115. United Kingdom Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 116. United Kingdom Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 117. United Kingdom Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 118. Netherlands Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 119. Netherlands Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 120. Netherlands Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 121. Netherlands Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 122. Netherlands Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 123. Rest of Europe Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 124. Rest of Europe Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 125. Rest of Europe Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 126. Rest of Europe Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 127. Rest of Europe Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 128. MEA Structural Heart Devices, by Country USD Million (2015-2020)
  • Table 129. MEA Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 130. MEA Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 131. MEA Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 132. MEA Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 133. MEA Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 134. Middle East Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 135. Middle East Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 136. Middle East Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 137. Middle East Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 138. Middle East Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 139. Africa Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 140. Africa Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 141. Africa Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 142. Africa Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 143. Africa Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 144. North America Structural Heart Devices, by Country USD Million (2015-2020)
  • Table 145. North America Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 146. North America Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 147. North America Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 148. North America Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 149. North America Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 150. United States Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 151. United States Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 152. United States Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 153. United States Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 154. United States Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 155. Canada Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 156. Canada Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 157. Canada Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 158. Canada Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 159. Canada Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 160. Mexico Structural Heart Devices, by Type USD Million (2015-2020)
  • Table 161. Mexico Structural Heart Devices, by Indication USD Million (2015-2020)
  • Table 162. Mexico Structural Heart Devices, by Procedure USD Million (2015-2020)
  • Table 163. Mexico Structural Heart Devices, by Age Group USD Million (2015-2020)
  • Table 164. Mexico Structural Heart Devices, by End User USD Million (2015-2020)
  • Table 165. Structural Heart Devices Sales: by Type(K Unit)
  • Table 166. Structural Heart Devices Sales Herat Valve Devices , by Region K Unit (2015-2020)
  • Table 167. Structural Heart Devices Sales Surgical Heart Valves , by Region K Unit (2015-2020)
  • Table 168. Structural Heart Devices Sales Transcatheter Heart Valves , by Region K Unit (2015-2020)
  • Table 169. Structural Heart Devices Sales Occluders and Delivery Systems , by Region K Unit (2015-2020)
  • Table 170. Structural Heart Devices Sales Annuloplasty Rings , by Region K Unit (2015-2020)
  • Table 171. Structural Heart Devices Sales Other Devices , by Region K Unit (2015-2020)
  • Table 172. Structural Heart Devices Sales Accessories , by Region K Unit (2015-2020)
  • Table 173. Structural Heart Devices Sales: by Indication(K Unit)
  • Table 174. Structural Heart Devices Sales Atrial Septal Defect (ASD) , by Region K Unit (2015-2020)
  • Table 175. Structural Heart Devices Sales Ventricular Septal Defect (VSD) , by Region K Unit (2015-2020)
  • Table 176. Structural Heart Devices Sales Patent Foramen Ovale (PFO) , by Region K Unit (2015-2020)
  • Table 177. Structural Heart Devices Sales Aortic Valve Stenosis , by Region K Unit (2015-2020)
  • Table 178. Structural Heart Devices Sales Others , by Region K Unit (2015-2020)
  • Table 179. Structural Heart Devices Sales: by Procedure(K Unit)
  • Table 180. Structural Heart Devices Sales Replacement Procedures , by Region K Unit (2015-2020)
  • Table 181. Structural Heart Devices Sales TAVR Procedures , by Region K Unit (2015-2020)
  • Table 182. Structural Heart Devices Sales SAVR Procedures , by Region K Unit (2015-2020)
  • Table 183. Structural Heart Devices Sales Repair Procedures , by Region K Unit (2015-2020)
  • Table 184. Structural Heart Devices Sales Closure Procedures , by Region K Unit (2015-2020)
  • Table 185. Structural Heart Devices Sales Annuloplasty , by Region K Unit (2015-2020)
  • Table 186. Structural Heart Devices Sales Valvuloplasty , by Region K Unit (2015-2020)
  • Table 187. Structural Heart Devices Sales TMVR Procedures , by Region K Unit (2015-2020)
  • Table 188. Structural Heart Devices Sales: by Age Group(K Unit)
  • Table 189. Structural Heart Devices Sales Pediatric , by Region K Unit (2015-2020)
  • Table 190. Structural Heart Devices Sales Adults , by Region K Unit (2015-2020)
  • Table 191. Structural Heart Devices Sales: by End User(K Unit)
  • Table 192. Structural Heart Devices Sales Hospitals , by Region K Unit (2015-2020)
  • Table 193. Structural Heart Devices Sales Ambulatory Surgical Centers , by Region K Unit (2015-2020)
  • Table 194. South America Structural Heart Devices Sales, by Country K Unit (2015-2020)
  • Table 195. South America Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 196. South America Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 197. South America Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 198. South America Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 199. South America Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 200. Brazil Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 201. Brazil Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 202. Brazil Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 203. Brazil Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 204. Brazil Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 205. Argentina Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 206. Argentina Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 207. Argentina Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 208. Argentina Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 209. Argentina Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 210. Rest of South America Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 211. Rest of South America Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 212. Rest of South America Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 213. Rest of South America Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 214. Rest of South America Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 215. Asia Pacific Structural Heart Devices Sales, by Country K Unit (2015-2020)
  • Table 216. Asia Pacific Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 217. Asia Pacific Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 218. Asia Pacific Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 219. Asia Pacific Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 220. Asia Pacific Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 221. China Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 222. China Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 223. China Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 224. China Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 225. China Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 226. Japan Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 227. Japan Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 228. Japan Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 229. Japan Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 230. Japan Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 231. India Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 232. India Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 233. India Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 234. India Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 235. India Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 236. South Korea Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 237. South Korea Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 238. South Korea Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 239. South Korea Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 240. South Korea Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 241. Taiwan Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 242. Taiwan Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 243. Taiwan Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 244. Taiwan Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 245. Taiwan Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 246. Australia Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 247. Australia Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 248. Australia Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 249. Australia Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 250. Australia Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 251. Rest of Asia-Pacific Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 252. Rest of Asia-Pacific Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 253. Rest of Asia-Pacific Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 254. Rest of Asia-Pacific Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 255. Rest of Asia-Pacific Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 256. Europe Structural Heart Devices Sales, by Country K Unit (2015-2020)
  • Table 257. Europe Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 258. Europe Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 259. Europe Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 260. Europe Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 261. Europe Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 262. Germany Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 263. Germany Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 264. Germany Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 265. Germany Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 266. Germany Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 267. France Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 268. France Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 269. France Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 270. France Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 271. France Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 272. Italy Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 273. Italy Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 274. Italy Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 275. Italy Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 276. Italy Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 277. United Kingdom Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 278. United Kingdom Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 279. United Kingdom Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 280. United Kingdom Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 281. United Kingdom Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 282. Netherlands Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 283. Netherlands Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 284. Netherlands Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 285. Netherlands Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 286. Netherlands Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 287. Rest of Europe Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 288. Rest of Europe Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 289. Rest of Europe Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 290. Rest of Europe Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 291. Rest of Europe Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 292. MEA Structural Heart Devices Sales, by Country K Unit (2015-2020)
  • Table 293. MEA Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 294. MEA Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 295. MEA Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 296. MEA Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 297. MEA Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 298. Middle East Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 299. Middle East Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 300. Middle East Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 301. Middle East Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 302. Middle East Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 303. Africa Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 304. Africa Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 305. Africa Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 306. Africa Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 307. Africa Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 308. North America Structural Heart Devices Sales, by Country K Unit (2015-2020)
  • Table 309. North America Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 310. North America Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 311. North America Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 312. North America Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 313. North America Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 314. United States Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 315. United States Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 316. United States Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 317. United States Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 318. United States Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 319. Canada Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 320. Canada Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 321. Canada Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 322. Canada Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 323. Canada Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 324. Mexico Structural Heart Devices Sales, by Type K Unit (2015-2020)
  • Table 325. Mexico Structural Heart Devices Sales, by Indication K Unit (2015-2020)
  • Table 326. Mexico Structural Heart Devices Sales, by Procedure K Unit (2015-2020)
  • Table 327. Mexico Structural Heart Devices Sales, by Age Group K Unit (2015-2020)
  • Table 328. Mexico Structural Heart Devices Sales, by End User K Unit (2015-2020)
  • Table 329. Structural Heart Devices: by Type(USD/Units)
  • Table 330. Company Basic Information, Sales Area and Its Competitors
  • Table 331. Company Basic Information, Sales Area and Its Competitors
  • Table 332. Company Basic Information, Sales Area and Its Competitors
  • Table 333. Company Basic Information, Sales Area and Its Competitors
  • Table 334. Company Basic Information, Sales Area and Its Competitors
  • Table 335. Company Basic Information, Sales Area and Its Competitors
  • Table 336. Company Basic Information, Sales Area and Its Competitors
  • Table 337. Company Basic Information, Sales Area and Its Competitors
  • Table 338. Company Basic Information, Sales Area and Its Competitors
  • Table 339. Company Basic Information, Sales Area and Its Competitors
  • Table 340. Structural Heart Devices: by Type(USD Million)
  • Table 341. Structural Heart Devices Herat Valve Devices , by Region USD Million (2021-2026)
  • Table 342. Structural Heart Devices Surgical Heart Valves , by Region USD Million (2021-2026)
  • Table 343. Structural Heart Devices Transcatheter Heart Valves , by Region USD Million (2021-2026)
  • Table 344. Structural Heart Devices Occluders and Delivery Systems , by Region USD Million (2021-2026)
  • Table 345. Structural Heart Devices Annuloplasty Rings , by Region USD Million (2021-2026)
  • Table 346. Structural Heart Devices Other Devices , by Region USD Million (2021-2026)
  • Table 347. Structural Heart Devices Accessories , by Region USD Million (2021-2026)
  • Table 348. Structural Heart Devices: by Indication(USD Million)
  • Table 349. Structural Heart Devices Atrial Septal Defect (ASD) , by Region USD Million (2021-2026)
  • Table 350. Structural Heart Devices Ventricular Septal Defect (VSD) , by Region USD Million (2021-2026)
  • Table 351. Structural Heart Devices Patent Foramen Ovale (PFO) , by Region USD Million (2021-2026)
  • Table 352. Structural Heart Devices Aortic Valve Stenosis , by Region USD Million (2021-2026)
  • Table 353. Structural Heart Devices Others , by Region USD Million (2021-2026)
  • Table 354. Structural Heart Devices: by Procedure(USD Million)
  • Table 355. Structural Heart Devices Replacement Procedures , by Region USD Million (2021-2026)
  • Table 356. Structural Heart Devices TAVR Procedures , by Region USD Million (2021-2026)
  • Table 357. Structural Heart Devices SAVR Procedures , by Region USD Million (2021-2026)
  • Table 358. Structural Heart Devices Repair Procedures , by Region USD Million (2021-2026)
  • Table 359. Structural Heart Devices Closure Procedures , by Region USD Million (2021-2026)
  • Table 360. Structural Heart Devices Annuloplasty , by Region USD Million (2021-2026)
  • Table 361. Structural Heart Devices Valvuloplasty , by Region USD Million (2021-2026)
  • Table 362. Structural Heart Devices TMVR Procedures , by Region USD Million (2021-2026)
  • Table 363. Structural Heart Devices: by Age Group(USD Million)
  • Table 364. Structural Heart Devices Pediatric , by Region USD Million (2021-2026)
  • Table 365. Structural Heart Devices Adults , by Region USD Million (2021-2026)
  • Table 366. Structural Heart Devices: by End User(USD Million)
  • Table 367. Structural Heart Devices Hospitals , by Region USD Million (2021-2026)
  • Table 368. Structural Heart Devices Ambulatory Surgical Centers , by Region USD Million (2021-2026)
  • Table 369. South America Structural Heart Devices, by Country USD Million (2021-2026)
  • Table 370. South America Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 371. South America Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 372. South America Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 373. South America Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 374. South America Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 375. Brazil Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 376. Brazil Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 377. Brazil Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 378. Brazil Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 379. Brazil Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 380. Argentina Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 381. Argentina Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 382. Argentina Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 383. Argentina Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 384. Argentina Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 385. Rest of South America Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 386. Rest of South America Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 387. Rest of South America Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 388. Rest of South America Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 389. Rest of South America Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 390. Asia Pacific Structural Heart Devices, by Country USD Million (2021-2026)
  • Table 391. Asia Pacific Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 392. Asia Pacific Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 393. Asia Pacific Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 394. Asia Pacific Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 395. Asia Pacific Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 396. China Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 397. China Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 398. China Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 399. China Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 400. China Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 401. Japan Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 402. Japan Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 403. Japan Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 404. Japan Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 405. Japan Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 406. India Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 407. India Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 408. India Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 409. India Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 410. India Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 411. South Korea Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 412. South Korea Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 413. South Korea Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 414. South Korea Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 415. South Korea Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 416. Taiwan Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 417. Taiwan Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 418. Taiwan Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 419. Taiwan Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 420. Taiwan Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 421. Australia Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 422. Australia Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 423. Australia Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 424. Australia Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 425. Australia Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 426. Rest of Asia-Pacific Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 427. Rest of Asia-Pacific Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 428. Rest of Asia-Pacific Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 429. Rest of Asia-Pacific Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 430. Rest of Asia-Pacific Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 431. Europe Structural Heart Devices, by Country USD Million (2021-2026)
  • Table 432. Europe Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 433. Europe Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 434. Europe Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 435. Europe Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 436. Europe Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 437. Germany Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 438. Germany Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 439. Germany Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 440. Germany Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 441. Germany Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 442. France Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 443. France Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 444. France Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 445. France Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 446. France Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 447. Italy Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 448. Italy Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 449. Italy Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 450. Italy Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 451. Italy Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 452. United Kingdom Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 453. United Kingdom Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 454. United Kingdom Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 455. United Kingdom Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 456. United Kingdom Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 457. Netherlands Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 458. Netherlands Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 459. Netherlands Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 460. Netherlands Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 461. Netherlands Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 462. Rest of Europe Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 463. Rest of Europe Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 464. Rest of Europe Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 465. Rest of Europe Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 466. Rest of Europe Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 467. MEA Structural Heart Devices, by Country USD Million (2021-2026)
  • Table 468. MEA Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 469. MEA Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 470. MEA Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 471. MEA Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 472. MEA Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 473. Middle East Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 474. Middle East Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 475. Middle East Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 476. Middle East Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 477. Middle East Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 478. Africa Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 479. Africa Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 480. Africa Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 481. Africa Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 482. Africa Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 483. North America Structural Heart Devices, by Country USD Million (2021-2026)
  • Table 484. North America Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 485. North America Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 486. North America Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 487. North America Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 488. North America Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 489. United States Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 490. United States Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 491. United States Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 492. United States Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 493. United States Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 494. Canada Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 495. Canada Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 496. Canada Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 497. Canada Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 498. Canada Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 499. Mexico Structural Heart Devices, by Type USD Million (2021-2026)
  • Table 500. Mexico Structural Heart Devices, by Indication USD Million (2021-2026)
  • Table 501. Mexico Structural Heart Devices, by Procedure USD Million (2021-2026)
  • Table 502. Mexico Structural Heart Devices, by Age Group USD Million (2021-2026)
  • Table 503. Mexico Structural Heart Devices, by End User USD Million (2021-2026)
  • Table 504. Structural Heart Devices Sales: by Type(K Unit)
  • Table 505. Structural Heart Devices Sales Herat Valve Devices , by Region K Unit (2021-2026)
  • Table 506. Structural Heart Devices Sales Surgical Heart Valves , by Region K Unit (2021-2026)
  • Table 507. Structural Heart Devices Sales Transcatheter Heart Valves , by Region K Unit (2021-2026)
  • Table 508. Structural Heart Devices Sales Occluders and Delivery Systems , by Region K Unit (2021-2026)
  • Table 509. Structural Heart Devices Sales Annuloplasty Rings , by Region K Unit (2021-2026)
  • Table 510. Structural Heart Devices Sales Other Devices , by Region K Unit (2021-2026)
  • Table 511. Structural Heart Devices Sales Accessories , by Region K Unit (2021-2026)
  • Table 512. Structural Heart Devices Sales: by Indication(K Unit)
  • Table 513. Structural Heart Devices Sales Atrial Septal Defect (ASD) , by Region K Unit (2021-2026)
  • Table 514. Structural Heart Devices Sales Ventricular Septal Defect (VSD) , by Region K Unit (2021-2026)
  • Table 515. Structural Heart Devices Sales Patent Foramen Ovale (PFO) , by Region K Unit (2021-2026)
  • Table 516. Structural Heart Devices Sales Aortic Valve Stenosis , by Region K Unit (2021-2026)
  • Table 517. Structural Heart Devices Sales Others , by Region K Unit (2021-2026)
  • Table 518. Structural Heart Devices Sales: by Procedure(K Unit)
  • Table 519. Structural Heart Devices Sales Replacement Procedures , by Region K Unit (2021-2026)
  • Table 520. Structural Heart Devices Sales TAVR Procedures , by Region K Unit (2021-2026)
  • Table 521. Structural Heart Devices Sales SAVR Procedures , by Region K Unit (2021-2026)
  • Table 522. Structural Heart Devices Sales Repair Procedures , by Region K Unit (2021-2026)
  • Table 523. Structural Heart Devices Sales Closure Procedures , by Region K Unit (2021-2026)
  • Table 524. Structural Heart Devices Sales Annuloplasty , by Region K Unit (2021-2026)
  • Table 525. Structural Heart Devices Sales Valvuloplasty , by Region K Unit (2021-2026)
  • Table 526. Structural Heart Devices Sales TMVR Procedures , by Region K Unit (2021-2026)
  • Table 527. Structural Heart Devices Sales: by Age Group(K Unit)
  • Table 528. Structural Heart Devices Sales Pediatric , by Region K Unit (2021-2026)
  • Table 529. Structural Heart Devices Sales Adults , by Region K Unit (2021-2026)
  • Table 530. Structural Heart Devices Sales: by End User(K Unit)
  • Table 531. Structural Heart Devices Sales Hospitals , by Region K Unit (2021-2026)
  • Table 532. Structural Heart Devices Sales Ambulatory Surgical Centers , by Region K Unit (2021-2026)
  • Table 533. South America Structural Heart Devices Sales, by Country K Unit (2021-2026)
  • Table 534. South America Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 535. South America Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 536. South America Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 537. South America Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 538. South America Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 539. Brazil Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 540. Brazil Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 541. Brazil Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 542. Brazil Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 543. Brazil Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 544. Argentina Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 545. Argentina Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 546. Argentina Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 547. Argentina Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 548. Argentina Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 549. Rest of South America Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 550. Rest of South America Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 551. Rest of South America Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 552. Rest of South America Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 553. Rest of South America Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 554. Asia Pacific Structural Heart Devices Sales, by Country K Unit (2021-2026)
  • Table 555. Asia Pacific Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 556. Asia Pacific Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 557. Asia Pacific Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 558. Asia Pacific Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 559. Asia Pacific Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 560. China Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 561. China Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 562. China Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 563. China Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 564. China Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 565. Japan Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 566. Japan Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 567. Japan Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 568. Japan Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 569. Japan Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 570. India Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 571. India Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 572. India Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 573. India Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 574. India Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 575. South Korea Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 576. South Korea Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 577. South Korea Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 578. South Korea Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 579. South Korea Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 580. Taiwan Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 581. Taiwan Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 582. Taiwan Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 583. Taiwan Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 584. Taiwan Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 585. Australia Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 586. Australia Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 587. Australia Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 588. Australia Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 589. Australia Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 590. Rest of Asia-Pacific Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 591. Rest of Asia-Pacific Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 592. Rest of Asia-Pacific Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 593. Rest of Asia-Pacific Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 594. Rest of Asia-Pacific Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 595. Europe Structural Heart Devices Sales, by Country K Unit (2021-2026)
  • Table 596. Europe Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 597. Europe Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 598. Europe Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 599. Europe Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 600. Europe Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 601. Germany Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 602. Germany Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 603. Germany Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 604. Germany Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 605. Germany Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 606. France Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 607. France Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 608. France Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 609. France Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 610. France Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 611. Italy Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 612. Italy Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 613. Italy Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 614. Italy Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 615. Italy Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 616. United Kingdom Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 617. United Kingdom Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 618. United Kingdom Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 619. United Kingdom Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 620. United Kingdom Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 621. Netherlands Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 622. Netherlands Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 623. Netherlands Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 624. Netherlands Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 625. Netherlands Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 626. Rest of Europe Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 627. Rest of Europe Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 628. Rest of Europe Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 629. Rest of Europe Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 630. Rest of Europe Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 631. MEA Structural Heart Devices Sales, by Country K Unit (2021-2026)
  • Table 632. MEA Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 633. MEA Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 634. MEA Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 635. MEA Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 636. MEA Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 637. Middle East Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 638. Middle East Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 639. Middle East Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 640. Middle East Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 641. Middle East Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 642. Africa Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 643. Africa Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 644. Africa Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 645. Africa Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 646. Africa Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 647. North America Structural Heart Devices Sales, by Country K Unit (2021-2026)
  • Table 648. North America Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 649. North America Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 650. North America Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 651. North America Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 652. North America Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 653. United States Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 654. United States Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 655. United States Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 656. United States Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 657. United States Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 658. Canada Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 659. Canada Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 660. Canada Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 661. Canada Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 662. Canada Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 663. Mexico Structural Heart Devices Sales, by Type K Unit (2021-2026)
  • Table 664. Mexico Structural Heart Devices Sales, by Indication K Unit (2021-2026)
  • Table 665. Mexico Structural Heart Devices Sales, by Procedure K Unit (2021-2026)
  • Table 666. Mexico Structural Heart Devices Sales, by Age Group K Unit (2021-2026)
  • Table 667. Mexico Structural Heart Devices Sales, by End User K Unit (2021-2026)
  • Table 668. Structural Heart Devices: by Type(USD/Units)
  • Table 669. Research Programs/Design for This Report
  • Table 670. Key Data Information from Secondary Sources
  • Table 671. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Structural Heart Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Structural Heart Devices: by Indication USD Million (2015-2020)
  • Figure 6. Global Structural Heart Devices: by Procedure USD Million (2015-2020)
  • Figure 7. Global Structural Heart Devices: by Age Group USD Million (2015-2020)
  • Figure 8. Global Structural Heart Devices: by End User USD Million (2015-2020)
  • Figure 9. South America Structural Heart Devices Share (%), by Country
  • Figure 10. Asia Pacific Structural Heart Devices Share (%), by Country
  • Figure 11. Europe Structural Heart Devices Share (%), by Country
  • Figure 12. MEA Structural Heart Devices Share (%), by Country
  • Figure 13. North America Structural Heart Devices Share (%), by Country
  • Figure 14. Global Structural Heart Devices: by Type K Unit (2015-2020)
  • Figure 15. Global Structural Heart Devices: by Indication K Unit (2015-2020)
  • Figure 16. Global Structural Heart Devices: by Procedure K Unit (2015-2020)
  • Figure 17. Global Structural Heart Devices: by Age Group K Unit (2015-2020)
  • Figure 18. Global Structural Heart Devices: by End User K Unit (2015-2020)
  • Figure 19. South America Structural Heart Devices Share (%), by Country
  • Figure 20. Asia Pacific Structural Heart Devices Share (%), by Country
  • Figure 21. Europe Structural Heart Devices Share (%), by Country
  • Figure 22. MEA Structural Heart Devices Share (%), by Country
  • Figure 23. North America Structural Heart Devices Share (%), by Country
  • Figure 24. Global Structural Heart Devices: by Type USD/Units (2015-2020)
  • Figure 25. Global Structural Heart Devices share by Players 2020 (%)
  • Figure 26. Global Structural Heart Devices share by Players (Top 3) 2020(%)
  • Figure 27. Global Structural Heart Devices share by Players (Top 5) 2020(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 32. Medtronic plc (Ireland) Revenue: by Geography 2020
  • Figure 33. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 34. Abbott (United States) Revenue: by Geography 2020
  • Figure 35. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 37. LivaNova plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. LivaNova plc (United Kingdom) Revenue: by Geography 2020
  • Figure 39. CryoLife, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. CryoLife, Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Micro Interventional Devices, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Micro Interventional Devices, Inc. (United States) Revenue: by Geography 2020
  • Figure 43. Braile Biomédica (Brazil) Revenue, Net Income and Gross profit
  • Figure 44. Braile Biomédica (Brazil) Revenue: by Geography 2020
  • Figure 45. Lepu Medical Technology (Beijing) Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 46. Lepu Medical Technology (Beijing) Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 47. TTK Healthcare Limited (India) Revenue, Net Income and Gross profit
  • Figure 48. TTK Healthcare Limited (India) Revenue: by Geography 2020
  • Figure 49. Global Structural Heart Devices: by Type USD Million (2021-2026)
  • Figure 50. Global Structural Heart Devices: by Indication USD Million (2021-2026)
  • Figure 51. Global Structural Heart Devices: by Procedure USD Million (2021-2026)
  • Figure 52. Global Structural Heart Devices: by Age Group USD Million (2021-2026)
  • Figure 53. Global Structural Heart Devices: by End User USD Million (2021-2026)
  • Figure 54. South America Structural Heart Devices Share (%), by Country
  • Figure 55. Asia Pacific Structural Heart Devices Share (%), by Country
  • Figure 56. Europe Structural Heart Devices Share (%), by Country
  • Figure 57. MEA Structural Heart Devices Share (%), by Country
  • Figure 58. North America Structural Heart Devices Share (%), by Country
  • Figure 59. Global Structural Heart Devices: by Type K Unit (2021-2026)
  • Figure 60. Global Structural Heart Devices: by Indication K Unit (2021-2026)
  • Figure 61. Global Structural Heart Devices: by Procedure K Unit (2021-2026)
  • Figure 62. Global Structural Heart Devices: by Age Group K Unit (2021-2026)
  • Figure 63. Global Structural Heart Devices: by End User K Unit (2021-2026)
  • Figure 64. South America Structural Heart Devices Share (%), by Country
  • Figure 65. Asia Pacific Structural Heart Devices Share (%), by Country
  • Figure 66. Europe Structural Heart Devices Share (%), by Country
  • Figure 67. MEA Structural Heart Devices Share (%), by Country
  • Figure 68. North America Structural Heart Devices Share (%), by Country
  • Figure 69. Global Structural Heart Devices: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Edwards Lifesciences Corporation (United States)
  • Medtronic plc (Ireland)
  • Abbott (United States)
  • Boston Scientific Corporation (United States)
  • LivaNova plc (United Kingdom)
  • CryoLife, Inc. (United States)
  • Micro Interventional Devices, Inc. (United States)
  • Braile Biomédica (Brazil)
  • Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • TTK Healthcare Limited (India)
Additional players considered in the study are as follows:
Biomerics (United States) , Lifetech Scientific (China)
Select User Access Type

Key Highlights of Report


Feb 2021 246 Pages 73 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Structural Heart Devices Quantitative research analysis
Global Structural Heart Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Structural Heart Devices Report?

Have a Query? Click Here

Other Related Reports

Blood Tubing Set Comprehensive Study by Type (Arterial Blood Tubing, Venous Blood Tubing), Application (Dialysis Centers, Hospitals, Clinics, Others), End-users (Adults, Children), Distribution Chann...
$ 3450
Medical Ultrasound System Comprehensive Study by Type (Portable, On Platform), Application (Multipurpose ultrasound imaging, Sonography, Gynaecological and obstetric ultrasound imaging, Cardiovascula...
$ 3750
Inferior Vena Cava Filter Comprehensive Study by Type (Retrievable Inferior Vena Cava Filter, Permanent Inferior Vena Cava Filter), Application (Treatment Venous Thromboembolism (VTE), Prevent Pulmon...
$ 3750
Safety Needles Comprehensive Study by Type (Active Safety Needles, Passive Safety Needles), End-users (Hospitals, Clinics, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmac...
$ 3350
Radiation Dosimeters Comprehensive Study by Type (Nuclear Radiation Detector , Personal Radiation Dosimeter), Application (Hospital , Clinic , Residential , Other ) Players and Region - Global Market...
$ 3500
Suction Tube Comprehensive Study by Type (Stainless Steel, Plastics, Others), Application (Otology, Rhinology, Laryngology, Others), End User (Private Hospitals, Government Hospitals, Others) Players...
$ 3500